John E. Bailey, Jr
2022
In 2022, John E. Bailey, Jr earned a total compensation of $3M as Chief Executive Officer and President at G1 Therapeutics, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $286,650 |
|---|---|
| Option Awards | $1,464,040 |
| Salary | $764,400 |
| Stock Awards | $491,740 |
| Other | $9,150 |
| Total | $3,015,980 |
Bailey received $1.5M in option awards, accounting for 49% of the total pay in 2022.
Bailey also received $286.7K in non-equity incentive plan, $764.4K in salary, $491.7K in stock awards and $9.2K in other compensation.
Rankings
In 2022, John E. Bailey, Jr's compensation ranked 1,212th out of 5,760 executives tracked by ExecPay. In other words, Bailey earned more than 79.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,212 out of 5,760 | 79th |
Division Manufacturing | 585 out of 3,136 | 81st |
Major group Chemicals And Allied Products | 214 out of 1,422 | 85th |
Industry group Drugs | 193 out of 1,323 | 85th |
Industry Pharmaceutical Preparations | 144 out of 969 | 85th |
Pay ratio
| John E. Bailey, Jr's Pay | $3,015,980 |
|---|---|
| Median Employee's Pay | $243,930 |
| Pay Ratio | 12to 1 |
In 2022, the annual total compensation of John E. Bailey, Jr was $3,015,980.
The annual total compensation of the median employee at G1 Therapeutics was $243,930.
The ratio of John E. Bailey, Jr's pay to the pay of median employee was therefore 12 to one.
Source: SEC filing on April 26, 2023.
Bailey's colleagues
We found two more compensation records of executives who worked with John E. Bailey, Jr at G1 Therapeutics in 2022.